M3 Wake Research
M3 Wake Research

M3 Wake Research Information

Contact top employees from M3 Wake Research

Summary

M3 Wake Research is a private company that has been in the industry for 42 years. The company currently specializes in the Biotechnology area. The position of the President & CEO is occupied by Ella Grach. Its headquarters is located at Raleigh, North Carolina, USA. The number of employees ranges from 25 to 100. The annual revenue of M3 Wake Research varies between 100K and 5.0M. To connect with M3 Wake Research employee register on SignalHire.

Organization Website

wakeresearch.com

Social Links

facebook

Phone Number

9197812514

Industries

Headquarters Location

3100 Duraleigh Rd, Raleigh, North Carolina, 27612 US

Employees Size

200-500 employees

Specialties

Phase I-IV Clinical Trial Conduct and Participant Recruitment/Retention in the Following Therapeutic Areas: Healthy Volunteer, Dermatology, Gastroenterology, Sleep Disorders, Men's/Woman's Health, Neurology, Vaccines, Pulmonology, Internal Medicine, Psychiatry

DMA Code

Research Triangle

Founded

1984

Estimated Annual Revenue

$100K - 5.0M

Operating Status

Independent Company

Competitors

Founded
Type
Employees
Revenue
Funding
1984Privately
Held
250 - 500 80M $0
1993- 10-50 - $-

Employees Turnover 4 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Number of employees by department
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at M3 Wake Research shows a diverse range of experience levels:
2% have been with the company for less than 1 year15% for 1–2 years32% for 3–4 years9% for 5–7 years9% for 8–10 years33% have over 11 years of service at M3 Wake Research
Ex-employees positions
In Company
In New Company
Contact top employees from M3 Wake Research
Lauri Befus
Vice President Operations
View
Marina Khrapavitskaya
Accounts Payable Coordinator
View
Felicia Irvin
Vice President of Business Development
View
Seth Rogers
Clinical Research Coordinator II
View
Kayla Cota
Clinical Research Coordinator
View
Stefanie Mullins
Clinical Research Coordinator
View
Jamari James
Front Desk Coordinator
View
Fabricio Nuñez
Clinical research coordinator II
View
Margaret Abuede
Clinical Research Coordinator
View
Adolfo DeLeon
Senior Clinical Research Coordinator
View
Jessica
Clinical Research Coordinator
View
Misti Jarrett
Senior Clinical Research Coordinator
View
Laura Canter
Clinical Trials Application Specialist
View
Amanda Iams
Senior Accountant
View
Kyle Albasi
Multimedia Developer
View
Brian Mason
Clinical Research Budgets and Contracts Specialist
View
Kelly Hahl
Associate Director of Business Development
View
Samuel Hickson
Clinical Trials Rater
View
Megan LaFountaine
Quality Control Specialist
View
Mercy Bishop
Sub-investigator
View
AUTUMN HOLDER
Sub-Investigator
View
Nadia Nguyen
Sub-investigator
View
Namrata Oza
Site Director Clinical Research Operations
View
Lara Wakeman
Manager, Site Advancement
View
Greg Moreno
Psychometric Rater
View
Tiffany Thomas
Clinical Research Assistant
View
Laurie Miles
Registered Nurse
View

FAQ

M3 Wake Research operates in the Pharma, Biotech industries. More details can be found on the official website: wakeresearch.com.
The headquarters of M3 Wake Research are located in Raleigh, United States.
The current CEO of M3 Wake Research is Ella Grach
You can contact M3 Wake Research by phone at 9197812514.
M3 Wake Research currently employs 200-500 people.
M3 Wake Research's revenue is approximately 1.8M.
Well-known competitors of M3 Wake Research include Rho and Gad Consulting Services.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP